511 related articles for article (PubMed ID: 9399948)
1. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.
James JA; Kaufman KM; Farris AD; Taylor-Albert E; Lehman TJ; Harley JB
J Clin Invest; 1997 Dec; 100(12):3019-26. PubMed ID: 9399948
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and systemic lupus erythematosus.
James JA; Harley JB; Scofield RH
Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
7. [Systemic lupus erythematosus and Epstein-Barr virus].
Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
[TBL] [Abstract][Full Text] [Related]
8. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
Rasmussen NS; Nielsen CT; Houen G; Jacobsen S
Lupus; 2016 Dec; 25(14):1567-1576. PubMed ID: 27084029
[TBL] [Abstract][Full Text] [Related]
9. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
Palafox Sánchez CA; Satoh M; Chan EK; Carcamo WC; Muñoz Valle JF; Orozco Barocio G; Oregon Romero E; Navarro Hernández RE; Salazar Páramo M; Cabral Castañeda A; Vázquez Del Mercado M
Arthritis Res Ther; 2009; 11(1):R27. PubMed ID: 19232124
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection induces lupus autoimmunity.
Harley JB; James JA
Bull NYU Hosp Jt Dis; 2006; 64(1-2):45-50. PubMed ID: 17121489
[TBL] [Abstract][Full Text] [Related]
11. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
12. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
Front Immunol; 2022; 13():830993. PubMed ID: 35251022
[TBL] [Abstract][Full Text] [Related]
13. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
[TBL] [Abstract][Full Text] [Related]
14. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
[TBL] [Abstract][Full Text] [Related]
15. High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus.
Tung YC; Ke LY; Tsai SM; Lu PL; Tsai WC
Int J Rheum Dis; 2013 Dec; 16(6):709-14. PubMed ID: 24283670
[TBL] [Abstract][Full Text] [Related]
16. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan.
Lu JJ; Chen DY; Hsieh CW; Lan JL; Lin FJ; Lin SH
Lupus; 2007; 16(3):168-75. PubMed ID: 17432101
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for visceral leishmaniasis: role of Epstein-Barr virus infection.
Louzir H; Triki H; Bennani S; Edelman L; Laouini D; Ben Ismail R; Joab I; Dellagi K
Arch Inst Pasteur Tunis; 1993; 70(3-4):357-62. PubMed ID: 7802490
[No Abstract] [Full Text] [Related]
18. Infectious antibodies in systemic lupus erythematosus patients.
Berkun Y; Zandman-Goddard G; Barzilai O; Boaz M; Sherer Y; Larida B; Blank M; Anaya JM; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1129-35. PubMed ID: 19880558
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus.
Lau CS; Yuen KY; Chan KH; Wong RW
Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.
Huggins ML; Todd I; Powell RJ
Rheumatol Int; 2005 Apr; 25(3):183-7. PubMed ID: 14666378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
